Review



patient-reported outcome measurement information system cognitive concerns and ability scale  (ProMIS Neurosciences)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    ProMIS Neurosciences patient-reported outcome measurement information system cognitive concerns and ability scale
    Self-Administered and Telephone-Administered Cognitive Screening.
    Patient Reported Outcome Measurement Information System Cognitive Concerns And Ability Scale, supplied by ProMIS Neurosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cognitive+function+scale/6+item+patient+reported+outcomes+measurement+information+system+cognitive+function+and+abilities+scales/pmc10852828-187-32-36
    Average 90 stars, based on 1 article reviews
    patient-reported outcome measurement information system cognitive concerns and ability scale - by Bioz Stars, 2026-09
    90/100 stars

    Images

    1) Product Images from "Cognitive Screening in Persons With Chronic Diseases in Primary Care"

    Article Title: Cognitive Screening in Persons With Chronic Diseases in Primary Care

    Journal: American Journal of Alzheimer's Disease and Other Dementias

    doi: 10.1177/1533317515577127

    Self-Administered and Telephone-Administered Cognitive Screening.
    Figure Legend Snippet: Self-Administered and Telephone-Administered Cognitive Screening.

    Techniques Used: Functional Assay, Concentration Assay, Modification, Battery

    Technology-Based Cognitive Screening Measures.
    Figure Legend Snippet: Technology-Based Cognitive Screening Measures.

    Techniques Used: Concentration Assay

    Related Articles

    Functional Assay:

    Article Title: Neurocognitive, Psychosocial, and Quality of Life Outcomes After Multisystem Inflammatory Syndrome in Children Admitted to the PICU*
    Article Snippet: Additionally, parent- and self-reported cognitive functions (Patient Reported Outcomes Measurement Information System [PROMIS]—Short Form V1.0—Cognitive Function) were assessed in this subsample.

    Article Title: Assessment of comorbid symptoms in pediatric autonomic dysfunction.
    Article Snippet: Purpose Pediatric patients with autonomic dysfunction and orthostatic intolerance (OI) often present with co-existing symptoms and signs that might or might not directly relate to the autonomic nervous system.. Our objective was to identify validated screening instruments to characterize these comorbidities and their impact on youth functioning.. Methods The Pediatric Assembly of the American Autonomic Society reviewed the current state of practice for identifying symptom comorbidities in youth with OI.


    Article Title: The impact of loneliness and social isolation during COVID-19 on cognition in older adults: a scoping review
    Article Snippet: Cognitive outcomes were assessed with the 6-item Patient Reported Outcomes Measurement Information System (PROMIS) Cognitive Function and Abilities Scales ( ).

    Article Title: The MASCC COG-IMPACT: An unmet needs assessment for cancer-related cognitive impairment impact developed by the Multinational Association of Supportive Care in Cancer.
    Article Snippet: The self-report survey (Step #7) included (1) demographic and clinical questions, (2) the MASCC COG-IMPACT, (3) the Depression Anxiety, and Stress Scale-21 (DASS-21) [36], (4) Cancer Survivors Unmet Needs Scale (CaSUN) [26], (5) Assessment of Quality of Life Scale (AQoL) 6D [37], (6) the Cognitive Symptom Checklist-Work (CSC-W) [24], (7) the Patient-Reported Outcomes Measurement Information System-Cognitive Function Scale 8a (PROMIS-COG) [38], and (8) the adapted Acceptability of Intervention Measure (AIM), Intervention Appropriateness Measure (IAM), and Feasibility of Intervention Measure (FIM) [39].

    Article Title: Neurologic Biomarkers, Neuroimaging, and Cognitive Function in Persistent Atrial Fibrillation: A Cross-Sectional Study.
    Article Snippet: A cognitive assessment was performed using the self-reported Patient-Reported Outcomes Measurement Information System (PROMIS) Cognitive Function Index, which consists of an eight item short form, as previously described [27].

    Activity Assay:

    Article Title: Neurocognitive, Psychosocial, and Quality of Life Outcomes After Multisystem Inflammatory Syndrome in Children Admitted to the PICU*
    Article Snippet: Additionally, parent- and self-reported cognitive functions (Patient Reported Outcomes Measurement Information System [PROMIS]—Short Form V1.0—Cognitive Function) were assessed in this subsample.

    Article Title: Assessment of comorbid symptoms in pediatric autonomic dysfunction.
    Article Snippet: Purpose Pediatric patients with autonomic dysfunction and orthostatic intolerance (OI) often present with co-existing symptoms and signs that might or might not directly relate to the autonomic nervous system.. Our objective was to identify validated screening instruments to characterize these comorbidities and their impact on youth functioning.. Methods The Pediatric Assembly of the American Autonomic Society reviewed the current state of practice for identifying symptom comorbidities in youth with OI.


    Article Title: The impact of loneliness and social isolation during COVID-19 on cognition in older adults: a scoping review
    Article Snippet: Cognitive outcomes were assessed with the 6-item Patient Reported Outcomes Measurement Information System (PROMIS) Cognitive Function and Abilities Scales ( ).

    Article Title: The MASCC COG-IMPACT: An unmet needs assessment for cancer-related cognitive impairment impact developed by the Multinational Association of Supportive Care in Cancer.
    Article Snippet: The self-report survey (Step #7) included (1) demographic and clinical questions, (2) the MASCC COG-IMPACT, (3) the Depression Anxiety, and Stress Scale-21 (DASS-21) [36], (4) Cancer Survivors Unmet Needs Scale (CaSUN) [26], (5) Assessment of Quality of Life Scale (AQoL) 6D [37], (6) the Cognitive Symptom Checklist-Work (CSC-W) [24], (7) the Patient-Reported Outcomes Measurement Information System-Cognitive Function Scale 8a (PROMIS-COG) [38], and (8) the adapted Acceptability of Intervention Measure (AIM), Intervention Appropriateness Measure (IAM), and Feasibility of Intervention Measure (FIM) [39].

    Article Title: Neurologic Biomarkers, Neuroimaging, and Cognitive Function in Persistent Atrial Fibrillation: A Cross-Sectional Study.
    Article Snippet: A cognitive assessment was performed using the self-reported Patient-Reported Outcomes Measurement Information System (PROMIS) Cognitive Function Index, which consists of an eight item short form, as previously described [27].

    Clinical Proteomics:

    Article Title: Neurocognitive, Psychosocial, and Quality of Life Outcomes After Multisystem Inflammatory Syndrome in Children Admitted to the PICU*
    Article Snippet: Additionally, parent- and self-reported cognitive functions (Patient Reported Outcomes Measurement Information System [PROMIS]—Short Form V1.0—Cognitive Function) were assessed in this subsample.

    Article Title: Assessment of comorbid symptoms in pediatric autonomic dysfunction.
    Article Snippet: Purpose Pediatric patients with autonomic dysfunction and orthostatic intolerance (OI) often present with co-existing symptoms and signs that might or might not directly relate to the autonomic nervous system.. Our objective was to identify validated screening instruments to characterize these comorbidities and their impact on youth functioning.. Methods The Pediatric Assembly of the American Autonomic Society reviewed the current state of practice for identifying symptom comorbidities in youth with OI.


    Article Title: The impact of loneliness and social isolation during COVID-19 on cognition in older adults: a scoping review
    Article Snippet: Cognitive outcomes were assessed with the 6-item Patient Reported Outcomes Measurement Information System (PROMIS) Cognitive Function and Abilities Scales ( ).

    Article Title: The MASCC COG-IMPACT: An unmet needs assessment for cancer-related cognitive impairment impact developed by the Multinational Association of Supportive Care in Cancer.
    Article Snippet: The self-report survey (Step #7) included (1) demographic and clinical questions, (2) the MASCC COG-IMPACT, (3) the Depression Anxiety, and Stress Scale-21 (DASS-21) [36], (4) Cancer Survivors Unmet Needs Scale (CaSUN) [26], (5) Assessment of Quality of Life Scale (AQoL) 6D [37], (6) the Cognitive Symptom Checklist-Work (CSC-W) [24], (7) the Patient-Reported Outcomes Measurement Information System-Cognitive Function Scale 8a (PROMIS-COG) [38], and (8) the adapted Acceptability of Intervention Measure (AIM), Intervention Appropriateness Measure (IAM), and Feasibility of Intervention Measure (FIM) [39].

    Article Title: Neurologic Biomarkers, Neuroimaging, and Cognitive Function in Persistent Atrial Fibrillation: A Cross-Sectional Study.
    Article Snippet: A cognitive assessment was performed using the self-reported Patient-Reported Outcomes Measurement Information System (PROMIS) Cognitive Function Index, which consists of an eight item short form, as previously described [27].



    Similar Products

    90
    ProMIS Neurosciences cognitive function scale
    Cognitive Function Scale, supplied by ProMIS Neurosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cognitive+function+scale/cognitive+function+scale/pmc12170308-290-9-9
    Average 90 stars, based on 1 article reviews
    cognitive function scale - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    ProMIS Neurosciences cognitive functioning scale
    Cognitive Functioning Scale, supplied by ProMIS Neurosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cognitive+function+scale/cognitive+function+scale/pm40424163-95-8-9
    Average 90 stars, based on 1 article reviews
    cognitive functioning scale - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    ProMIS Neurosciences 32-item patient-reported outcomes measurement information system (promis®) itembank v2.0 - cognitive function scale
    32 Item Patient Reported Outcomes Measurement Information System (Promis®) Itembank V2.0 Cognitive Function Scale, supplied by ProMIS Neurosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cognitive+function+scale/32+item+patient+reported+outcomes+measurement+information+system++promis+++itembank+v2+0+++cognitive+function+scale/pm40318391-61-13-17
    Average 90 stars, based on 1 article reviews
    32-item patient-reported outcomes measurement information system (promis®) itembank v2.0 - cognitive function scale - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Tokyo Chemical Industry eortc qlq-c30 cognitive functioning scale
    Included Studies.
    Eortc Qlq C30 Cognitive Functioning Scale, supplied by Tokyo Chemical Industry, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cognitive+function+scale/qlq+c30/pmc11940014-8-62-49
    Average 90 stars, based on 1 article reviews
    eortc qlq-c30 cognitive functioning scale - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    ProMIS Neurosciences cognitive function 4a scale
    Included Studies.
    Cognitive Function 4a Scale, supplied by ProMIS Neurosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cognitive+function+scale/anxiety+short+form+8a/pmc12153818-72-2-1
    Average 90 stars, based on 1 article reviews
    cognitive function 4a scale - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    ProMIS Neurosciences promis® v2.0 short form cognitive function scale
    Included Studies.
    Promis® V2.0 Short Form Cognitive Function Scale, supplied by ProMIS Neurosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cognitive+function+scale/promis+cognitive+scales/pm39940051-70-1-0
    Average 90 stars, based on 1 article reviews
    promis® v2.0 short form cognitive function scale - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    ProMIS Neurosciences short form cognitive function scale promis v2.0
    Included Studies.
    Short Form Cognitive Function Scale Promis V2.0, supplied by ProMIS Neurosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cognitive+function+scale/promis+cognitive+scales/pm39940051-281-83-88
    Average 90 stars, based on 1 article reviews
    short form cognitive function scale promis v2.0 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    Included Studies.

    Journal: Cancers

    Article Title: Immune Checkpoint Inhibitors and Cognition in Adults with Cancer: A Scoping Review

    doi: 10.3390/cancers17060928

    Figure Lengend Snippet: Included Studies.

    Article Snippet: Rogiers et al., 2023 [ ] Belgium/Luxembourg , n = 125 (prospectively enrolled patients) Median age-60 yr (range 29–85 yr) Female-72 Male-80 Melanoma-152 Nivolumab-152 , Longitudinal study (assessments at baseline, 9 months, 18 months—6 months post-therapy) EORTC QLQ-C30 cognitive functioning scale [ ] “ Threshold for clinical importance ” (TCI) = score < 75 [ ] , Baseline ( n = 125): EORTC QLQ-C30 cognitive functioning scale—mean 89.6 (SD +/− 19.7) [Not statistically significantly different from European reference values; European mean—84.8 (SD +/− 21.3) [ ]] 17% patients score < TCI ( n = 123) 3 months: 28% patients score < TCI ( n = 95) 18 months: 34% patients score < TCI ( n = 59) “ Although cognitive functioning mean scores remained stable, they decreased (deteriorated) and approached prespecified thresholds for MIDs (minimally important differences)” .

    Techniques: Concentration Assay, Functional Assay, Control